Literature DB >> 14491800

The relationships between serum complement activity and the development of allergic lesions in rabbits.

M B RHYNE, F G GERMUTH.   

Abstract

Total serum hemolytic complement activity is consistently reduced in animals undergoing accelerated "serum sickness". The time of maximum reduction in complement titer invariably coincides with the time of complete antigen disappearance. This temporal relationship supports the belief that the reduction in complement titer is brought about by in vivo antigen-antibody combination. The intravenous administration of a single daily large dose of BGG-precipitated complexes produces a marked but temporary reduction in total complement hemolytic activity. On the other hand, multiple injections of soluble BGG immune complexes prepared in antigen excess failed to even temporarily alter complement titers. Animals undergoing the development of accelerated "serum sickness" treated by either type immune complex showed a significantly reduced incidence of arterial lesions. Apparently, this inhibiting effect on the development of arterial lesions was independent of variations in total complement hemolytic activity.

Entities:  

Keywords:  ALLERGY/experimental; COMPLEMENT

Mesh:

Substances:

Year:  1961        PMID: 14491800      PMCID: PMC2180371          DOI: 10.1084/jem.114.5.633

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Inhibition of immune hemolysis by diisopropyl fluorophosphate.

Authors:  L LEVINE
Journal:  Biochim Biophys Acta       Date:  1955-10

2.  Studies on the biological properties of antigen-antibody complexes. I. Anaphylatic shock induced by soluble antigen-antibody complexes in unsensitized normal guinea pigs.

Authors:  F G GERMUTH; G E MCKINNON
Journal:  Bull Johns Hopkins Hosp       Date:  1957-07

3.  The relationships between the chemical nature of the antigen, antigen dosage, rate of antibody synthesis and the occurrence of arteritis and glomerulonephritis in experimental hypersensitivity.

Authors:  F G GERMUTH; C FLANAGAN; M R MONTENEGRO
Journal:  Bull Johns Hopkins Hosp       Date:  1957-09

4.  Concerning the mechanism of complement action. I. Inhibition of complement activity by diisopropyl fluophosphate.

Authors:  E L BECKER
Journal:  J Immunol       Date:  1956-12       Impact factor: 5.422

5.  Elution of an esterase from antigen-antibody aggregates treated with human complement.

Authors:  I H LEPOW; O D RATNOFF; L PILLEMER
Journal:  Proc Soc Exp Biol Med       Date:  1956-05

6.  An investigation of some of the factors determining the decrease in complement activity in anaphylactic shock.

Authors:  C E RICE
Journal:  J Immunol       Date:  1955-08       Impact factor: 5.422

7.  A comparative histologic and immunologic study in rabbits of induced hypersensitivity of the serum sickness type.

Authors:  F G GERMUTH
Journal:  J Exp Med       Date:  1953-02-01       Impact factor: 14.307

8.  Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis.

Authors:  F J DIXON; J D FELDMAN; J J VAZQUEZ
Journal:  J Exp Med       Date:  1961-05-01       Impact factor: 14.307

9.  Studies on the mechanism of hypersensitivity phenomena. III. The participation of complement in the formation of anaphylatoxin.

Authors:  A G OSLER; H G RANDALL; B M HILL; Z OVARY
Journal:  J Exp Med       Date:  1959-08-01       Impact factor: 14.307

10.  Studies on the mechanism of hypersensitivity phenomena. II. The participation of complement in passive cutaneous anaphylaxis of the albino rat.

Authors:  A G OSLER; M M HAWRISIAK; Z OVARY; M SIQUEIRA; O G BIER
Journal:  J Exp Med       Date:  1957-12-01       Impact factor: 14.307

View more
  6 in total

1.  HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID.

Authors:  T J PEKIN; N J ZVAIFLER
Journal:  J Clin Invest       Date:  1964-07       Impact factor: 14.808

Review 2.  [ACTH AND CORTICOID TREATMENT OF NEUROLOGIC DISEASES].

Authors:  H BAMMER
Journal:  Dtsch Z Nervenheilkd       Date:  1963-07-10

3.  Evidence for the involvement of IgE-basophil system in acute serum sickness.

Authors:  J Benveniste; J Egido; V Gutierrez-Millet
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

4.  Acute immune complex disease in rabbits. The role of complement and of a leukocyte-dependent release of vasoactive amines from platelets.

Authors:  P M Henson; C G Cochrane
Journal:  J Exp Med       Date:  1971-03-01       Impact factor: 14.307

5.  PATHOGENIC FACTORS IN VASULAR LESIONS OF EXPERIMENTAL SERUM SICKNESS.

Authors:  W T KNIKER; C G COCHRANE
Journal:  J Exp Med       Date:  1965-07-01       Impact factor: 14.307

6.  Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor.

Authors:  J Benveniste; P M Henson; C G Cochrane
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.